Three CPGs specifically counsel against routine APOE testing for diagnosing or predicting AD (Hort et al., 2010; National Institute for Health and Care Excellence, 2018; The Royal College of Psychiatrists, 2023). Here, APOE is linked to Alzheimer disease.